HERG1 and CA IX expression are associated with disease recurrence in surgically resected clear cell renal carcinoma. Issue 1 (January 2020)
- Record Type:
- Journal Article
- Title:
- HERG1 and CA IX expression are associated with disease recurrence in surgically resected clear cell renal carcinoma. Issue 1 (January 2020)
- Main Title:
- HERG1 and CA IX expression are associated with disease recurrence in surgically resected clear cell renal carcinoma
- Authors:
- Lastraioli, E.
Pillozzi, S.
Mari, A.
Tellini, R.
Duranti, C.
Baldazzi, V.
Venturini, S.
Minervini, A.
Lapini, A.
Nesi, G.
Carini, M.
Arcangeli, A. - Abstract:
- Abstract: Background: In search of novel prognostic biomarkers for clear cell renal carcinoma (ccRCC), we analysed the expression of several proteins related to angiogenesis and hypoxia. Methods: A monocentric study on 30 consecutive surgical samples from surgically-treated ccRCC patients with a 10-year follow up was performed. The following proteins were analysed by immunohistochemistry: Vascular Endothelial Growth Factor- A (VEGF-A), Platelet-Derived Growth Factor β Receptor (PDGFRβ), VEGF-receptor 1 (Flt1), VEGF-receptor 2 (KDR), Glucose Transporter 1 (GLUT1), Carbonic anhydrase IX (CA-IX) and the hERG1 potassium channel. Data were analysed in conjunction with the clinico-pathological characteristics of the patients and follow up. Results: All the proteins were expressed in the samples, with statistically significant associations of VEGF-A with PDGFRβ and Flt1 and hERG1 with CA IX. Notably, hERG1 and CAIX co-immunoprecipitated in primary ccRCC samples and survival analysis showed that the positivity for hERG1 and CA IX had a negative impact on Recurrence Free Survival (RFS) at the univariate analysis. At the multivariate analysis only hERG1 maintained its statistically significant negative impact. Conclusions: hERG1 expression can be exploited to predict recurrence in surgically-treated ccRCC patients. hERG1 channels form a multiprotein complex with the pH regulator CA IX in primary ccRCC samples their potential use as therapeutic target might be suggested.
- Is Part Of:
- European journal of surgical oncology. Volume 46:Issue 1(2020)
- Journal:
- European journal of surgical oncology
- Issue:
- Volume 46:Issue 1(2020)
- Issue Display:
- Volume 46, Issue 1 (2020)
- Year:
- 2020
- Volume:
- 46
- Issue:
- 1
- Issue Sort Value:
- 2020-0046-0001-0000
- Page Start:
- 209
- Page End:
- 215
- Publication Date:
- 2020-01
- Subjects:
- hERG1 -- CA IX -- Multiprotein complex -- Renal tumours -- Prognosis
Oncology -- Periodicals
Cancer -- Surgery -- Periodicals
Medical Oncology -- Periodicals
Neoplasms -- surgery -- Periodicals
Cancer -- Chirurgie -- Périodiques
Cancérologie -- Périodiques
Oncologie
Chirurgie (geneeskunde)
Electronic journals
Electronic journals -- Sciences
Electronic journals -- Medicine
Electronic journals
616.994059005 - Journal URLs:
- http://www.ejso.com/ ↗
http://www.sciencedirect.com/science/journal/07487983 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/07487983 ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/0720048X ↗
http://firstsearch.oclc.org ↗
http://firstsearch.oclc.org/journal=0748-7983;screen=info;ECOIP ↗
http://www.elsevier.com/journals ↗
http://www.harcourt-international.com/journals ↗
http://www.idealibrary.com/cgi-bin/links/toc/ejso ↗ - DOI:
- 10.1016/j.ejso.2019.10.031 ↗
- Languages:
- English
- ISSNs:
- 0748-7983
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3829.745500
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 12514.xml